The HIV Research for Prevention conference (HIVR4P) took place in Chicago, USA from 17-21 October 2016.

Conference highlights

Access to PrEP in the US

Some of the Americans who need PrEP the most face the greatest barriers to getting it.

HIV vaccine research

Huge diversity in current HIV vaccine research, HIVR4P conference hears.

PrEP 'in the wild'

Policy makers’ inaction is leading people to take PrEP ‘in the wild'.

PrEP and drug-resistant HIV

Second case report of PrEP failure due to drug-resistant virus.

Conference bulletin

Catch up on news from the HIVR4P conference in our summary bulletin.

HIV prevention for women

Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives.

aidsmap news from HIVR4P 2016

← First1Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more on the official conference website.

Visit the conference website >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.